Wegovy and Ozempic owner dealt blow as next-gen weight-loss drug is branded ‘obsolete’

--------------------------------------------------------------------
Source: Guardian Australia
Published: 2026-02-24 01:26 UTC+10:00
Section: Pharmaceuticals industry
Factuality Score: 100
Opinion Category: Neutral
Topics: Drugs
--------------------------------------------------------------------
Snippet:
Novo Nordisk’s shares fall sharply after testing of CagriSema falls short of investors’ expectations
--------------------------------------------------------------------
>>> Read full article at Guardian Australia <<<
<-- Back to Home
< >
[Close]